|
gptkbp:instanceOf
|
hemoglobin-based oxygen carrier
|
|
gptkbp:administeredBy
|
intravenous infusion
|
|
gptkbp:alsoKnownAs
|
gptkb:Hemopure
|
|
gptkbp:approvedBy
|
gptkb:Russia
gptkb:South_Africa
|
|
gptkbp:clinicalTrialPhase
|
Phase III
|
|
gptkbp:color
|
dark purple
|
|
gptkbp:compatibleWith
|
gptkb:United_States
cross-matching
blood type matching
|
|
gptkbp:composition
|
purified, polymerized bovine hemoglobin
|
|
gptkbp:contraindication
|
known hypersensitivity to bovine proteins
|
|
gptkbp:derivedFrom
|
bovine hemoglobin
|
|
gptkbp:developedBy
|
gptkb:Hemoglobin_Oxygen_Therapeutics_LLC
|
|
https://www.w3.org/2000/01/rdf-schema#label
|
HBOC-201
|
|
gptkbp:indication
|
treatment of acute anemia
when blood transfusion is not an option
|
|
gptkbp:molecularWeight
|
250 kDa
|
|
gptkbp:shelfLife
|
3 years
|
|
gptkbp:sideEffect
|
gptkb:methemoglobinemia
hypertension
gastrointestinal symptoms
|
|
gptkbp:storage
|
2-25°C
|
|
gptkbp:usedFor
|
oxygen therapeutics
blood substitute
|
|
gptkbp:usedIn
|
gptkb:veterinary_medicine
military medicine
surgery
emergency medicine
trauma care
|
|
gptkbp:bfsParent
|
gptkb:Hemopure
|
|
gptkbp:bfsLayer
|
8
|